Skip to main content

Education/ACR/EULAR

computer.health.jpg (keep)

Women Doctors More Likely to Be Called By First Name in Patient Messages

Oct 05, 2022

Female physicians were more likely to be called by their first names in electronic medical record (EMR) patient portal messaging, researchers found.



In adjusted analyses, women doctors were more than twice as likely as their male counterparts to be addressed by their first name in

Read Article
Five Senses of Medicine - nice graphic download on Clinical Skils (from Annals of Internal Medicine) https://t.co/8RNpqovtVP https://t.co/FkOSZCtv8c
Interesting read on "The art of paying attention" Narrative medicine: "attention, representation, and affiliation" “noticing the words we usually ignore” “taking the temperature of the conversation.” “meta-questions”, like “How are we doing so far? https://t.co/Pvx2GOQTgd https://t.co/wswf7Enaie
RheumNow Podcast square

Great and Not So Great (9.30.2022)

Sep 30, 2022

This week it's the great and not-so-great on gout, chondrocalcinosis, osteoporosis and misdiagnosis. We are good at many of those things - what's not so great? Let's review the news and journal reports from the past week on RheumNow.

Read Article
Lasker,award,science,biomedical

2022 Lasker Award Winners

EurekAlert!
Sep 29, 2022

The Lasker Foundation has announced the winners of its 2022 Lasker Awards, widely regarded as America’s top biomedical research prize since its creation more than 75 years ago. Here's a look at the award winners and their important contributions to biomedical research.

Read Article
ASBMR 2022 study shows Patients w/ serum ferritin > 1000 µg/L or Dx hemochromatosis or thalassemia — were 60% more likely to have an osteoporotic fracture (2X risk vertebral Fx) during an up to 10-year follow-up https://t.co/uLf8zTiMml https://t.co/9KnApUxxTF
ACR20 Capitol

Rheumatology Leaders and Patient Advocates Convene on Capitol Hill

ACR
Sep 26, 2022

ACR members along with rheumatology patients gathered on Capitol Hill and urged federal lawmakers to support the HELP Copays Act, Safe Step Act, and Improving Seniors’ Timely Access to Care Act.

Read Article
RheumNow Podcast square

Heavy Metal Rheumatology (9.23.2022)

Sep 23, 2022

Below are this week’s highlights from RheumNow, as discussed by Dr. Jack Cush. Thanks to all of you for your kind comments and great reviews of our weekly podcast. Please let us know how we can improve by emailing me or recording your suggestion using the "Ask Cush Anything" link on our website

Read Article
Are we set for the next "Twindemic"? - Continuation and evolution of COVID BA.5 to? - Flourishing Influenza in a population who has vaccine burnout? Some predicting severe flu based on Australia’s 2022 flu season, climate change, more https://t.co/qWuhWjaAFa
voices.jpg

USPSTF Recommends Screening for Anxiety and Depression

Sep 22, 2022

The U.S. Preventive Services Task Force has recommended that general practitioners actively screen and identify anxiety and depression in all adult patients under 65 yrs.



The USPSTF was appointed by the Department of Health and Human Services, and has been working on this guideline

Read Article
ACR's State-by-State Report Cards for Rheumatic Disease New report examines access, affordability, and activity and lifestyle factors in all 50 states and DC evaluating how easy it is to live with a rheumatic disease in your state. https://t.co/MmzG9oTfnq https://t.co/UhSM22PMf5
#ACR22 abstracts: 0220 Do you think social media can enhance your rheuma medical education, research or professional development? @anzypanzywanzy @anjmsantiago @PhRheumaJr @rheum4you @RHEUMarampa @RheumaRambolMD @doktora_ging #ACRambassador 📌https://t.co/SZB4p0WNu8
antibody (Keep)

Clinical Profiles Seen with NXP-2 Antibodies

Sep 20, 2022

A recent review of the myositis associated autoantibody NXP-2 profiles its clinical associations with dermatomyositis (DM), calcinosis, severe myositis and, in some reports, with cancer.

Read Article
USA,States,map

ACR's State-by-State Report Cards for Rheumatic Disease

Sep 19, 2022

New report examines access, affordability, and activity and lifestyle factors in all 50 states and the District of Columbia, evaluating how easy it is to live with a rheumatic disease in your state. No state scored an "A" or "F", and only two states improved their 2018 grades.

Read Article
Doctor Appointment Wait Times are Up Forbes reports that a recent Merritt Hawkins survey shows that patients are waiting an average of 26 days for a scheduled appointment with a doctor.https://t.co/qYfTf2Kxlv https://t.co/BuvihCk0M6
2022 New ACR Guidance on Glucocorticoid-Induced Osteoporosis (GIOP) The ACR has updated this guideline and includes recommendations on abaloparatide (PTHrP) and romosozumab, which are newly available since the ACR’s 2017 GIOP guideline.https://t.co/byehJlihCY https://t.co/xnKPC1V0l7
The 2022 ACR abstracts are published and posted for you. Let the Learning begin! https://t.co/fNkzQVXHJx https://t.co/9AuamLB0Ha
RheumNow Podcast square

CD19 CAR T Cell Therapy in SLE (9.16.2022)

Sep 16, 2022

The big news this week: the approval of deucravacitinib (a new class of drug?) for psoriasis; the 2022 ACR guidance on glucocorticoid-induced osteoporosis; a national poll of older adults over the age of 50 who claimed self-reported or doctor-diagnosed arthritis; and much more. Let's review

Read Article
Ischemic Forearm Exercise Test - used by McArdle, notes absence of elevated blood lactate levels during exercise w/ myophosphorylase deficiency (McArdle Dz). Deficiency impairs impairs glycogen metabolism & Nl lactate production in muscle https://t.co/t4PS1ghj5d https://t.co/YUDM1GCOfn
2022 Univ of Michigan Natl Poll on Healthy Aging finds that 70% of older adults reported joint pain (more in Women 75% vs 65%M). 30% have a HCP dx of #OA, 8% RA, 7% gout or pseudogout & 5% w/ another kind of arthritis https://t.co/yno8RgCRQS https://t.co/yTMLHsbGOU
New download available! COVID Deaths at 3 Mos vs. 30 Mos https://t.co/SLGJGh5NX1 https://t.co/QhWdvNHntk
op.compare.jpg

2022 New ACR Guidance on Glucocorticoid-Induced Osteoporosis (GIOP)

ACR
Sep 14, 2022

The ACR has updated this guideline and includes recommendations on abaloparatide (PTHrP) and romosozumab, which are newly available since the ACR’s 2017 GIOP guideline.



It also addresses sequential therapy, which was not addressed in the past. Patients need to understand that when

Read Article
joint.pain_.hand_.PIP_.jpg

70% of Older Adults Report Joint Pain

Sep 14, 2022

Dr. Beth Wallace and colleagues at the University of Michigan surveyed a national sample of older adults (50–80 yrs) and found that 70% currently report experiencing joint pain and 60% reported being told by a health care professional that they have arthritis. 

Read Article
The 2022 ACR abstracts are published and posted for you. Let the Learning begin! https://t.co/ZqMAc8jV3U https://t.co/3iCGnzsPI5
The ACR is developing a new clinical practice guideline for systemic autoimmune rheumatic disease with interstitial lung disease (ILD). The Call for Public Comment is open until September 29, 2022. https://t.co/UxXDbGEQlh https://t.co/zGoBpbKLTC
×